1 min read
Add as a preferred source on Google

SELLAS Prices $150 Million Stock Offering at $13 a Share

The offering covers 11.54 million common shares, with gross proceeds expected to total $150 million before discounts, commissions and other expenses.

Share certificates rest beside a glass vial in a quiet laboratory / TokenPost.ai (macro)
Share certificates rest beside a glass vial in a quiet laboratory / TokenPost.ai (macro)

SELLAS Life Sciences Group priced 11.54 million common shares at $13 each, setting expected gross proceeds at $150 million before underwriting discounts, commissions and offering expenses.

The pricing advances the public offering the company began Nov. 17. SELLAS previously reported positive results from its Phase 3 REGAL trial in patients with acute myeloid leukemia, including a statistically significant improvement in overall survival. The offering follows that earlier development and is separate from the trial results.

Read more about SELLAS’ launch of the $150 million stock offering.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…